Hiroaki Suga
The University of Tokyo, JAPAN, Japan
- This delegate is presenting an abstract at this event.
 
      
        Hiroaki Suga is a Professor of the Department of Chemistry, Graduate School of Science in the University of Tokyo since 2010. He received Ph.D. at MIT (1994). He was tenured Associate Professor in the State University of New York at Buffalo (1997-2003) and Professor in the Research Center for Advanced Science and Technology in the University of Tokyo (2003-2010). He is the recipient of Akabori Memorial Award 2014, Max-Bergmann Medal 2016, Vincent du Vigneaud Award 2019, MIT TY Shen Lecture 2022, ETHZ Prelog Medal 2022, Research Award of the Alexander von Humboldt Foundation 2020, Hisayuki Matsuo Award 2022 etc.. He is also a founder of PeptiDream and MiraBiologics in Japan.      
      Presentations this author is a contributor to:
                  
          
          Ribosomal synthesis of macrocyclic D/L-α/β/γ-hybrid peptide libraries for discovery of IFNGR1 inhibitors (#312)
  
  7:30 PM
      
    Takashi Miura    
  
          
            
            Poster Session 2 - Wine Tasting          
        
                        
          
          Discovery of novel RaPID-derived macrocyclic peptide for blockade of the CD24-Siglec-10 interaction as a potential immune checkpoint inhibitor (#258)
  
  7:30 PM
      
    Wei-En Huang    
  
          
            
            Poster Session 1 - Wine Tasting          
        
                        
          
          Switching prenyl donor specificities in cyanobactin prenyltransferases to access unprecedent prenylation modes (#76)
  
  4:35 PM
      
    Yuki Goto    
  
          
            
            SESSION 14: Chemical Biology           
        
                        
          
          Development of bifunctional antibody with immune checkpoint inhibitory effect using Lasso-grafting (#395)
  
  7:30 PM
      
    Jinxuan ZHAO    
  
          
            
            Poster Session 2 - Wine Tasting          
        
                        
          
          Macrocyclic peptides with better membrane permeability (#4)
  
  8:30 AM
      
    Hiroaki Suga    
  
          
            
            SESSION 2:  Synthetic and Biosynthetic Technologies